ZOGENIX, INC. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 20 rows in 2017. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2017-12-11: Reporting owner HAWLEY ROGER; Form 4; Security Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2017-12-11: Reporting owner HAWLEY ROGER; Form 4; Security Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2017-12-11: Reporting owner HAWLEY ROGER; Form 4; Security Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2017-12-08: Reporting owner HAWLEY ROGER; Form 4; Security Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2017-12-11 | HAWLEY ROGER Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −44,741 53,461 owned after | $15.04 exercise price | 2017-12-11 | |
| 2017-12-11 | HAWLEY ROGER Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −8,462 10,417 owned after | $10.64 exercise price | 2017-12-11 | |
| 2017-12-11 | HAWLEY ROGER Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 10,000 owned after | $12.75 exercise price | 2017-12-11 | |
| 2017-12-08 | HAWLEY ROGER Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −11,797 98,202 owned after | $15.04 exercise price | 2017-12-11 | |
| 2017-12-07 | HAWLEY ROGER Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −15,000 109,999 owned after | $15.04 exercise price | 2017-12-11 | |
| 2017-12-07 | HAWLEY ROGER Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −12,370 18,879 owned after | $10.64 exercise price | 2017-12-11 | |
| 2017-12-07 | HAWLEY ROGER Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −9,000 0 owned after | $12.80 exercise price | 2017-12-11 | |
| 2017-12-07 | HAWLEY ROGER Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −20,000 0 owned after | $8.99 exercise price | 2017-12-11 | |
| 2017-05-23 | TANNENBAUM RENEE P Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $12.75 exercise price | 2017-05-23 | |
| 2017-05-23 | MAST ERLE T Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $12.75 exercise price | 2017-05-23 | |
| 2017-05-23 | HAWLEY ROGER Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $12.75 exercise price | 2017-05-23 | |
| 2017-05-23 | BREITMEYER JAMES B Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $12.75 exercise price | 2017-05-23 | |
| 2017-05-23 | BOCK LOUIS C Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $12.75 exercise price | 2017-05-23 | |
| 2017-05-23 | WIGGINS MARK C Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $12.75 exercise price | 2017-05-23 | |
| 2017-05-23 | GARNER CAM L Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $12.75 exercise price | 2017-05-23 | |
| 2017-03-14 | Farfel Gail M Officer (EVP/Chief Development Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +52,500 52,500 owned after | $10.20 exercise price | 2017-03-16 | |
| 2017-03-14 | Galer Bradley S. Officer (EVP/Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +60,000 60,000 owned after | $10.20 exercise price | 2017-03-16 | |
| 2017-03-14 | FARR STEPHEN J Director, Officer (President and CEO) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +165,000 165,000 owned after | $10.20 exercise price | 2017-03-16 | |
| 2017-03-14 | Darcis Thierry J.P. Officer (EVP / General Manager, Europe) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +52,500 52,500 owned after | $10.20 exercise price | 2017-03-16 | |
| 2017-01-16 | Smith Michael P Officer (EVP, CFO, Treasurer & Sec.) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +135,000 135,000 owned after | $10.35 exercise price | 2017-01-18 |